| 标题 |
 PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; nivolumab plus ipilimumab for hepatocellular carcinoma, fedratinib for myelofibrosis, talquetamab for multiple myeloma, and belzutifan for tumors associated with von Hippel-Lindau disease and renal cell carcinoma |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
小牛马阿欢
渡人舟
invisight
mmmm
song
嘻嘻哈哈
152455
乐空思
老实灵安
My_magnum_opus
Yinxb
OK
GingerF
DW
anyue
QM
殷勤的紫槐
Banff
初景
牧青
皖公网安备34019202002308
